Assessing Change in Spine Bone Density from Different Numbers and Combinations of Lumbar Vertebrae: The Manitoba BMD Registry
- PMID: 38643731
- DOI: 10.1016/j.jocd.2024.101493
Assessing Change in Spine Bone Density from Different Numbers and Combinations of Lumbar Vertebrae: The Manitoba BMD Registry
Abstract
Introduction: Change in bone mineral density (BMD) is considered significant when it exceeds the 95 % least significant change (LSC) derived from that facility's precision study. The lumbar spine is often affected by structural artifact such that not all four lumbar vertebrae are evaluable. Guidelines suggest using a site-matched LSC when omitting vertebrae from the BMD measurement. The current study describes significant BMD change related to intervening anti-osteoporosis treatment for different numbers and combinations of lumbar vertebrae using site-matched LSC values.
Methodology: We identified 10,526 untreated adult women mean age 59.6 years with baseline and repeat spine BMD testing (mean interval 4.7 years) where all 4 lumbar vertebrae were evaluable. Change in spine BMD for different combinations of lumbar vertebrae was assessed in relation to intervening anti-resorptive treatment, contrasting women with high treatment exposure (medication possession ratio, MPR ≥ 0.8) versus women who remained untreated. Site-matched LSC values were derived from 879 test-retest precision measurements.
Results: There was consistent linear trend between increasing MPR and BMD change exceeding the LSC for all lumbar vertebral combinations, positive with BMD increase and negative with BMD decrease (all p-trend <0.001). In the high treatment exposure group, mean percent increases in spine BMD were similar for all vertebral combinations, from L1-4 to a single vertebra. In untreated women, mean percent decreases in spine BMD were also similar for all vertebral combinations. The net treatment response (proportion of women with treatment-concordant changes minus proportion with treatment-discordant changes exceeding the LSC) was 29.7 % for 4 vertebrae, 27.5-30.0 % for 3 vertebrae, 22.4-28.5 % for 2 vertebrae, and 18.1-21.9 % for a single vertebra.
Conclusions: All numbers and combinations of lumbar vertebrae, when used in conjunction with site-matched LSC values, can provide clinically meaningful follow-up in treated and untreated patients, even when spine BMD is based on a single vertebral body.
Keywords: Bone mineral density; Dual-energy x-ray absorptiometry; Least significant change; Monitoring; Osteoporosis.
Copyright © 2024 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Bone Mineral Density Monitoring in Contiguous versus Non-Contiguous Lumbar Vertebrae: The Manitoba BMD Registry.J Clin Densitom. 2024 Oct-Dec;27(4):101520. doi: 10.1016/j.jocd.2024.101520. Epub 2024 Aug 13. J Clin Densitom. 2024. PMID: 39182384
-
Estimating Lumbar Spine Least Significant Change for Fewer than Four Vertebrae: The Manitoba BMD Registry.J Clin Densitom. 2024 Apr-Jun;27(2):101483. doi: 10.1016/j.jocd.2024.101483. Epub 2024 Mar 6. J Clin Densitom. 2024. PMID: 38479135
-
Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.Osteoporos Int. 2019 Jul;30(7):1445-1453. doi: 10.1007/s00198-019-04975-y. Epub 2019 Apr 23. Osteoporos Int. 2019. PMID: 31016351
-
Reporting Fewer Than Four Vertebrae: 2023 Official Positions of the International Society for Clinical Densitometry.J Clin Densitom. 2024 Jan-Mar;27(1):101436. doi: 10.1016/j.jocd.2023.101436. Epub 2023 Oct 31. J Clin Densitom. 2024. PMID: 37985274 Review.
-
Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.Clin Ther. 2008 Mar;30(3):443-52. doi: 10.1016/j.clinthera.2008.03.008. Clin Ther. 2008. PMID: 18405784 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical